Exploratory single-cell multiomics suggests naive CD4+ T cell dysregulation in treatment refractory rheumatoid arthritis
Summary Around 20% of patients with rheumatoid arthritis (RA) have disease that remains refractory to multiple targeted treatments, highlighting a major clinical challenge. We determine single-nucleus transcriptional and chromatin landscapes (10x Genomics Epi Multiome) on 14,625 primary CD4+ T-cells isolated from treat...